Compare GHRS & AEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GHRS | AEVA |
|---|---|---|
| Founded | 2018 | 2019 |
| Country | Ireland | United States |
| Employees | N/A | 276 |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 947.2M | 819.5M |
| IPO Year | 2021 | N/A |
| Metric | GHRS | AEVA |
|---|---|---|
| Price | $16.58 | $14.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $41.38 | $26.50 |
| AVG Volume (30 Days) | 140.6K | ★ 1.1M |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $85.37 |
| Revenue Next Year | N/A | $132.72 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.66 | $6.11 |
| 52 Week High | $19.51 | $38.79 |
| Indicator | GHRS | AEVA |
|---|---|---|
| Relative Strength Index (RSI) | 62.71 | 56.75 |
| Support Level | $12.34 | $12.17 |
| Resistance Level | $19.26 | $17.27 |
| Average True Range (ATR) | 0.81 | 1.06 |
| MACD | 0.33 | 0.14 |
| Stochastic Oscillator | 88.84 | 88.22 |
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.